Attached files
| file | filename |
|---|---|
| 10-K - FORM 10K - TOKEN COMMUNITIES LTD. | pmge10k63017_10k.htm |
| EX-31.2 - EXHIBIT 31.2 - TOKEN COMMUNITIES LTD. | exhibit312_ex31z2.htm |
| EX-31.1 - EXHIBIT 31.1 - TOKEN COMMUNITIES LTD. | exhibit311_ex31z1.htm |
EXHIBIT 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Extract Pharmaceuticals, Inc. (the “Company”), for the year ended June 30, 2017, as filed with the Securities and Exchange Commission (the “Report”), the undersigned, Peter E. Maddocks, chief executive officer of the Company and chief financial officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
By:
/s/ Peter E. Maddocks
Peter E. Maddocks
Chief Executive Officer and Chief Financial Officer
Dated: September 28, 2017